Lung Cancer Trial, Recruiting (NCT06504927)

Lung Cancer Trial, Recruiting NCT06504927 Sponsor: University of Malaya Condition: Lung Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06504927 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Lung Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 30 or older, of any gender
People with no previous history of any type of cancer
People who are able to provide chest X-ray and/or low-dose CT scan (LDCT) results
People who have been diagnosed with COPD, or who have small spots on the lung (called pulmonary nodules) measuring less than 11mm, or whose doctor has decided a biopsy is not needed
People who are willing to return for a follow-up X-ray or LDCT scan at their next scheduled medical appointment as part of their usual care
People who are willing to provide up to 30mL of blood (roughly 2 tablespoons) at the first visit, and up to 21mL at the second visit

Who may not be able to join:

People who have previously received chemotherapy, radiotherapy, or any other cancer-related treatment
People who are currently pregnant or breastfeeding (based on self-declaration)
People who are unwilling or unable to sign a consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Mau Ern Poh, University of Malaya

Phone: +60379494422

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06504927

Sponsor: University of Malaya

Phase: Not Applicable

Status: Recruiting

Condition: Lung Cancer

Trial contact: +60379494422

More information: https://clinicaltrials.gov/study/NCT06504927

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 30 or older, of any gender
People with no previous history of any type of cancer
People who are able to provide chest X-ray and/or low-dose CT scan (LDCT) results
People who have been diagnosed with COPD, or who have small spots on the lung (called pulmonary nodules) measuring less than 11mm, or whose doctor has decided a biopsy is not needed
People who are willing to return for a follow-up X-ray or LDCT scan at their next scheduled medical appointment as part of their usual care
People who are willing to provide up to 30mL of blood (roughly 2 tablespoons) at the first visit, and up to 21mL at the second visit

Who may not be able to join:

People who have previously received chemotherapy, radiotherapy, or any other cancer-related treatment
People who are currently pregnant or breastfeeding (based on self-declaration)
People who are unwilling or unable to sign a consent form agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Malaya

Registry

ClinicalTrials.gov

Start date

16 January 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇲🇾 Malaysia

Primary endpoints

To discover and validate RNA and methylated cell-free DNA cancer biomarkers that can discriminate between high-risk and lung cancer patients.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov